165 related articles for article (PubMed ID: 36602781)
21. Exon 5 of the RET proto-oncogene: a newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg.
Dvorakova S; Vaclavikova E; Duskova J; Vlcek P; Ryska A; Bendlova B
J Endocrinol Invest; 2005 Nov; 28(10):905-9. PubMed ID: 16419493
[TBL] [Abstract][Full Text] [Related]
22. [Familial medullary thyroid carcinoma: case report and literature review.].
Barletta Carrillo CF; Poterico Rojas JA; Barrionuevo Cornejo C; Casavilca Zambrano S; Pinedo Cárdenas A; Quispe Santibañez I; Castro Mujica MDC
Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):303-309. PubMed ID: 30734711
[TBL] [Abstract][Full Text] [Related]
23. Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection.
Huang Q; Hu A; Zhang M
BMC Endocr Disord; 2020 May; 20(1):64. PubMed ID: 32408902
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes.
Bussières V; Roy S; Deladoey J; Rousseau É; St-Vil D; Piché N
J Pediatr Surg; 2018 Feb; 53(2):283-285. PubMed ID: 29336779
[TBL] [Abstract][Full Text] [Related]
26. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
[TBL] [Abstract][Full Text] [Related]
27. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.
Rich TA; Feng L; Busaidy N; Cote GJ; Gagel RF; Hu M; Jimenez C; Lee JE; Perrier N; Sherman SI; Waguespack SG; Ying A; Grubbs E
Thyroid; 2014 Jul; 24(7):1096-106. PubMed ID: 24617864
[TBL] [Abstract][Full Text] [Related]
28. Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.
Basaran MN; Tuna MM; Karakılıç E; Doğan BA; İmga NN; Berker D; Güler S
J Endocrinol Invest; 2015 May; 38(5):541-6. PubMed ID: 25501606
[TBL] [Abstract][Full Text] [Related]
29. Genetics of medullary thyroid cancer: An overview.
Accardo G; Conzo G; Esposito D; Gambardella C; Mazzella M; Castaldo F; Di Donna C; Polistena A; Avenia N; Colantuoni V; Giugliano D; Pasquali D
Int J Surg; 2017 May; 41 Suppl 1():S2-S6. PubMed ID: 28506408
[TBL] [Abstract][Full Text] [Related]
30. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Romei C; Tacito A; Molinaro E; Agate L; Bottici V; Viola D; Matrone A; Biagini A; Casella F; Ciampi R; Materazzi G; Miccoli P; Torregrossa L; Ugolini C; Basolo F; Vitti P; Elisei R
Clin Endocrinol (Oxf); 2015 Jun; 82(6):892-9. PubMed ID: 25440022
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.
Frank-Raue K; Buhr H; Dralle H; Klar E; Senninger N; Weber T; Rondot S; Höppner W; Raue F
Eur J Endocrinol; 2006 Aug; 155(2):229-36. PubMed ID: 16868135
[TBL] [Abstract][Full Text] [Related]
32. Temporal trends in referrals of RET gene carriers for neck surgery to a tertiary surgical center in the era of international management guidelines.
Machens A; Lorenz K; Huessler EM; Stang A; Weber F; Dralle H
Endocrine; 2023 Apr; 80(1):100-110. PubMed ID: 36456885
[TBL] [Abstract][Full Text] [Related]
33. Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene.
Konstantinou E; Sapsakos Mariolis T; Fotis T; Mitsos A; Restos S; Mamoura K; Soultati A; Elefsiniotis I; Kapellakis G
Pediatr Endocrinol Rev; 2010 Dec; 8(2):108-13. PubMed ID: 21150841
[TBL] [Abstract][Full Text] [Related]
34. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
36. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
37. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
Toledo SP; dos Santos MA; Toledo Rde A; Lourenço DM
Clinics (Sao Paulo); 2006 Feb; 61(1):59-70. PubMed ID: 16532227
[TBL] [Abstract][Full Text] [Related]
38. Current understanding and management of medullary thyroid cancer.
Roy M; Chen H; Sippel RS
Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
[TBL] [Abstract][Full Text] [Related]
39. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
Wang J; Zhang B; Liu W; Zhang Y; Di X; Yang Y; Yan D
Fam Cancer; 2016 Jan; 15(1):99-104. PubMed ID: 26254625
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.
Lau GS; Lang BH; Lo CY; Tso A; Garcia-Barcelo MM; Tam PK; Lam KS
Hong Kong Med J; 2009 Oct; 15(5):326-31. PubMed ID: 19801688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
